Diabetes is a highly complex disease that entails a range of screening methods, treatment, monitoring, and management. Comprised of pre-diabetes, Type 1 (an autoimmune disease) and Type 2 (a metabolic disorder), diabetes affects 23.6 million people in the U.S., with another 57 million considered pre-diabetic, which typically evolves into Type 2. This report analyzes the prevalence, incidence, monitoring and treatment involved in managing diabetes, and also provides analysis of:
The risk factors for contraction, including overweight/obesity, age, ethnicity, family history of diabetes, high blood pressure and high cholesterol, as well as other factors
The overall national costs of managing the condition
The growth of the monitoring market through FDMx channels and direct suppliers
Competition between glucose monitor manufacturers, which strive to make monitoring glucose levels more convenient and painless through a range of technical innovations
Drivers for the diabetic market, including population growth among key demographics such as older Americans and ethnic groups
(0 items)
